Solitral Capsule ER

Introduction

Solitral ER is a prescription medication that contains two active ingredients: Alfuzosin and Solifenacin. It is primarily used to treat symptoms associated with an enlarged prostate gland, such as difficulty urinating, frequent urination, and urgency.

Uses

Solitral ER is prescribed to improve urinary symptoms in men with an enlarged prostate, a condition known as benign prostatic hyperplasia (BPH). It helps to relax the muscles in the prostate and bladder, allowing for easier urination and reducing urinary urgency.

Dosage and Administration

Solitral ER should be taken orally, with or without food, as directed by your healthcare provider. The recommended dose is one capsule per day, usually taken in the morning. Swallow the capsule whole, without crushing or chewing it, to ensure the medication is released gradually over time.

Mechanism of Action

The active ingredients in Solitral ER work in different ways to improve urinary symptoms. Alfuzosin belongs to a class of medications called alpha blockers, which relax the muscles in the prostate and bladder neck, making it easier to urinate. Solifenacin is classified as an antimuscarinic agent, which helps to reduce bladder muscle contractions and control urinary urgency.

Side Effects

Common side effects may include dizziness, headache, dry mouth, constipation, and blurred vision. These side effects are generally mild and temporary. However, if you experience any serious side effects such as chest pain, irregular heartbeat, severe dizziness, or difficulty urinating, seek medical attention immediately.

Drug Interactions

Solitral ER may interact with certain medications, so inform your healthcare provider about all the medications, supplements, and herbal products you are taking. It is particularly important to avoid combining Solitral ER with other medications that have anticholinergic effects, as this may increase the risk of side effects.

Precautions

Before starting Solitral ER, inform your healthcare provider about any medical conditions you have, especially liver or kidney problems. This medication may not be suitable for individuals with certain conditions or taking certain medications. Disclose your complete medical history and current medication list to ensure safe and effective use of Solitral ER.

Storage

Solitral ER should be stored at room temperature, away from moisture, heat, and direct light. Keep the medication out of reach of children and pets. Do not use Solitral ER beyond its expiration date, which is printed on the packaging.

Patient Tips

• Take Solitral ER exactly as prescribed by your healthcare provider.
• If you miss a dose, take it as soon as you remember. However, if it is close to the time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• Avoid activities that require alertness, such as driving or operating machinery, if you experience dizziness or blurred vision while taking Solitral ER.
• Stay hydrated and drink plenty of fluids to help prevent constipation, a possible side effect of this medication.
• If you have any questions or concerns about Solitral ER, consult your healthcare provider for further guidance.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Solifenacin – a medicine for treating symptoms of an overactive bladder (NHS UK) [Accessed 26 Jun. 2024] (online) Available at:
• Alfresed 7.5mg/5ml Syrup (Health Professionals SmPC) Available at:
• Alfuzosin (Drugs.com) [Accessed 9 Jun. 2024] (online) Available at:
• alfuzosin hcl er (RX) [Accessed 2 Jun. 2024] (online) Available at:
• Alfuzosin (MedlinePlus) [Accessed 12 Jun. 2024] (online) Available at:
• [No authors listed] Alfuzosin. 2018 Jan 8. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury [Internet]. Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases; 2012–. [Accessed 10 Jun. 2024] Available at: